Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pseudomembranous Colitis Caused by C. difficile.

Surawicz1, McFarland

  • 1Division of Gastroenterology, Box 359773, Harborview Medical Center, 325 9th Avenue, Seattle, WA 98104, USA.

Current Treatment Options in Gastroenterology
|November 30, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[In Process Citation]

Der Orthopade·2000
Same author

First laboratory observation of freely propagating electrostatic waves produced by intense, localized field structures

Physical review letters·2000
Same author

Combinatorial approaches to materials discovery.

Trends in biotechnology·1999
Same author

Assessing animal priorities: future directions.

Animal behaviour·1998
Same author

Productivity of Educational Psychologists in Educational Psychology Journals, 1991-1996

Contemporary educational psychology·1998
Same author

A rare-earth phosphor containing one-dimensional chains identified through combinatorial methods

Science (New York, N.Y.)·1998
Same journal

Esophageal Disorders in the Older Adult.

Current treatment options in gastroenterology·2025
Same journal

Endobariatrics: a Still Underutilized Weight Loss Tool.

Current treatment options in gastroenterology·2023
Same journal

Management of Post Ablative Barrett's Esophagus: a Review of Current Practices and Look at Emerging Technologies.

Current treatment options in gastroenterology·2023
Same journal

Inflammatory Bowel Disease Therapy and Venous Thromboembolism.

Current treatment options in gastroenterology·2023
Same journal

Ileal Pouch-Anal Anastomosis in the Older Adult: a Review of Postoperative Outcomes and Pouchitis Treatment.

Current treatment options in gastroenterology·2023
Same journal

Celiac Disease in the Elderly.

Current treatment options in gastroenterology·2023
See all related articles

Pseudomembranous colitis (PMC), a severe C. difficile infection, is treated with metronidazole or vancomycin. Recurrent cases benefit from antibiotics plus biotherapeutics, while prevention requires hygiene and antibiotic stewardship.

Area of Science:

  • Infectious Diseases
  • Gastroenterology
  • Microbiology

Background:

  • Pseudomembranous colitis (PMC) presents significant clinical challenges due to its severity, rising incidence, potential complications, and association with antibiotic-resistant bacteria.
  • Clostridioides difficile (C. difficile) infection is a primary cause of PMC, particularly in patients experiencing diarrhea during or after antibiotic treatment.

Purpose of the Study:

  • To outline the current understanding and management strategies for pseudomembranous colitis.
  • To provide guidance on the appropriate use of antibiotics and biotherapeutics for C. difficile infections and recurrent disease.

Main Methods:

  • Review of existing literature on C. difficile infection and PMC.
  • Analysis of treatment guidelines for metronidazole and vancomycin efficacy.

Related Experiment Videos

  • Discussion of strategies for managing recurrent C. difficile disease and preventing hospital-acquired infections.

    • Main Results:

    • Metronidazole is recommended as the first-line treatment for PMC, with vancomycin reserved for severe cases or treatment failures.
    • Recurrent C. difficile infections are effectively managed with a combination of antibiotics and biotherapeutic agents.
    • Effective prevention strategies include rigorous hand hygiene, environmental disinfection, and judicious antibiotic use.

    Conclusions:

    • Optimal management of PMC involves appropriate antibiotic selection and consideration of biotherapeutics for recurrent disease.
    • Preventing the spread of C. difficile requires a multi-faceted approach including infection control measures and antibiotic stewardship.